Evonik, University of Mainz to commercialize a new class of PEG lipids for nucleic acid delivery
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Combines biocompatibility, heat-resistance, transparency and durability
The company will be preferred business partner for VPPL in terms of sourcing and supplying key raw materials
TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union
The LyondellBasell CirculenRenew polymers are made from renewable feedstocks derived from bio-based wastes
The new ECO grade is made using renewable feedstock
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Alignment of carbon-fiber can be controlled during the 3D printing process
Diofan Ultra736 provides ultra-high water vapor barrier with excellent thermoformability, unlocking the potential to design thinner and more sustainable blister films
Subscribe To Our Newsletter & Stay Updated